Myriad Genetics Inc (MYGN)
Debt-to-assets ratio
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 39,000 | 38,800 | 38,700 | 38,500 | 38,500 | 38,400 | — | 0 | — | — | — | 0 | 0 | 0 | — | — | 224,400 | 225,200 | 225,100 | 225,000 |
Total assets | US$ in thousands | 1,081,300 | 1,085,100 | 1,110,500 | 1,146,500 | 1,149,100 | 1,187,200 | 1,169,300 | 1,198,700 | 1,212,000 | 1,210,200 | 1,255,400 | 1,320,700 | 1,335,900 | 1,360,300 | 1,336,900 | 1,444,500 | 1,404,600 | 1,446,700 | 1,578,300 | 1,591,200 |
Debt-to-assets ratio | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.16 | 0.14 | 0.14 |
September 30, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $39,000K ÷ $1,081,300K
= 0.04
The debt-to-assets ratio for Myriad Genetics Inc has exhibited a consistent and low trend over the most recent quarters, standing at 0.04 as of September 30, 2024. This indicates that only a small portion of the company's assets are financed through debt, suggesting a low level of financial risk. The ratio has remained relatively stable in the range of 0.03 to 0.04 in the past year, reflecting the company's conservative approach to leverage.
In the earlier periods, from 2020 to early 2022, the debt-to-assets ratio was notably higher, peaking at 0.16 in September 2020. However, since then, Myriad Genetics has significantly reduced its reliance on debt for funding, gradually improving the financial health and stability of the business. The successive decreases in the ratio signify a positive trend towards a stronger financial position with a lower debt burden.
The company's strategy of maintaining a low debt-to-assets ratio is beneficial for its long-term sustainability, as it indicates a prudent approach to managing debt levels and financial obligations. Overall, the consistently low debt-to-assets ratio of Myriad Genetics suggests a solid financial foundation and responsible financial management practices.
Peer comparison
Sep 30, 2024